CNBX PHARMACEUTICALS INC. Unrealized Gain (Loss) on Derivatives
CNBX PHARMACEUTICALS INC. (CNBX) reported Unrealized Gain (Loss) on Derivatives of $0 for the 12-month period ending 2019-08-31, per its 10-K filed 2019-11-29.
Discontinued › Cash Flow › Operating Activities
us-gaap:UnrealizedGainLossOnDerivatives · last filed 2019-11-29
- CNBX PHARMACEUTICALS INC. unrealized gain (loss) on derivatives for fiscal 2019 was $0.00, a 100.00% decline from fiscal 2018.
- CNBX PHARMACEUTICALS INC. unrealized gain (loss) on derivatives for fiscal 2018 was $64.91K.
- CNBX PHARMACEUTICALS INC. unrealized gain (loss) on derivatives for fiscal 2017 was -$69.03K.
- CNBX PHARMACEUTICALS INC. unrealized gain (loss) on derivatives for fiscal 2016 was -$712.00.
| Period end | Unrealized Gain (Loss) on Derivatives 12 month | Unrealized Gain (Loss) on Derivatives 12 month as first filed |
|---|---|---|
| 2019-08-31 | $0.00 10-K · filed 2019-11-29 | |
| 2018-08-31 | $64.91K 10-K · filed 2019-11-29 | |
| 2017-08-31 | -$69.03K 10-K · filed 2018-11-29 | -$64.65K 10-K · filed 2017-12-08 |
| 2016-08-31 | -$712.00 10-K · filed 2017-12-08 | |
| 2015-08-31 | $0.00 10-K · filed 2016-12-13 |